ascopubs.org2d
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Over the past 15 years, the landscape ...
ascopubs.org2d
The role of stereotactic radiotherapy in brain metastases from gastrointestinal cancer.
A phase 1 trial of folinic acid, fluorouracil, oxaliplatin, bevacizumab, botensilimab, balstilimab (FOLFOX-3B) in microsatellite stable metastatic colorectal cancer. Phase I/II trial of encorafenib, ...
ascopubs.org2d
The prevalence and prognostic significance of KRAS G12C mutation in metastatic colorectal cancer.
Deep learning–powered analysis of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does ...
ascopubs.org3d
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers
NOTE. P < .00357 represents statistical significance after the Bonferroni correction. Abbreviations: MAPK, mitogen-activated protein kinase; NA, unable to be calculated; NR, not reached; OS, overall ...
ascopubs.org3d
Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy
Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival We performed a single-institution retrospective analysis of patients with R/M HNSCC treated ...
ascopubs.org4d
Comprehensive analysis of socioeconomic and clinical factors contributing to treatment delay in early-onset colorectal cancer.
Comprehensive analysis of Native Hawaiians and other Pacific Islanders with early-onset colorectal cancer. Univariate and multivariate analysis of time from diagnosis to treatment.
ascopubs.org4d
Prognosis of signet ring cell (SRC) gastric carcinoma (GC) compared with other histological subtypes.
Prognostic impact of postoperative complications after neoadjuvant therapy followed by esophagectomy for esophageal cancer: An exploratory analysis of phase III trial JCOG1109.
ascopubs.org4d
Impact of inpatient palliative care on end-of-life care among patients with early-onset colorectal cancer.
Impact of synchronous vs metachronous primary tumor resection on prognosis of BRAF-V600E mutant metastatic colorectal cancer (mCRC). A randomized phase 2 study of an individualized ...
ascopubs.org4d
Real-world evidence on genomic profiles and survival outcomes in patients with HER2-positive metastatic colorectal cancer.
Effectiveness of anti-epidermal growth factor receptor agents in elderly patients (age ≥ 70 years) with RAS wild-type metastatic colorectal cancer: Nationwide real-world data. This is an ASCO Meeting ...
ascopubs.org4d
BREAKWATER: Analysis of first-line encorafenib + cetuximab + chemotherapy in BRAF V600E-mutant metastatic colorectal cancer.
Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort. Final analysis of ...
ascopubs.org4d
Disparities in incidence and mortality of colorectal cancer in Appalachian Kentucky.
Comprehensive analysis of socioeconomic and clinical factors contributing to treatment delay in early-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
ascopubs.org4d
Incidence trends of early-onset colorectal cancer (EOCRC) in the United States, by age, sex, race and ethnicity, and urbanicity (2000-2021).
Association of social deprivation and colon cancer mortality: A population-based analysis. Comparative analysis of demographics and outcomes in hospitalized patients with young- versus average-onset ...